Adult immunization policies in advanced economies: Vaccination recommendations, financing, and vaccination coverage

International Journal of Public Health

Volumn 58, Issue 6, 2013, Pages 865-874

  Wu, Lauren A ^a   Kanitz, Elisabeth ^b   Crumly, Julie ^c   D'Ancona, Fortunato ^b   Strikas, Raymond A ^d  

^a U S DEPARTMENT OF HEALTH AND HUMAN SERVICES   (United States)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^c OAK RIDGE INSTITUTE FOR SCIENCE AND EDUCATION   (United States)

^d NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

Author keywords

Adult immunization; Advanced economy; Developed country; Vaccination coverage; Vaccination policy; Vaccine financing

Indexed keywords

VACCINE;

ADOLESCENT; ADULT; AGED; ARTICLE; DEVELOPED COUNTRY; ECONOMICS; HEALTH CARE FINANCING; HEALTH CARE SURVEY; HUMAN; IMMUNIZATION; MIDDLE AGED; ORGANIZATION AND MANAGEMENT; PRACTICE GUIDELINE; PREVENTIVE HEALTH SERVICE; STANDARD; STATISTICS; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; DEVELOPED COUNTRIES; HEALTH CARE SURVEYS; HEALTHCARE FINANCING; HUMANS; IMMUNIZATION PROGRAMS; IMMUNIZATION SCHEDULE; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; VACCINES; YOUNG ADULT;

EID: 84890551898     PISSN: 16618556     EISSN: 1420911X     Source Type: Journal    
DOI: 10.1007/s00038-012-0438-x     Document Type: Article

References (46)

1. Advisory Committee on Immunization Practices (1990) Protection against viral hepatitis. Recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR Recomm Rep 39:1-26
2. Advisory Council for the Elimination of Tuberculosis and Advisory Committee on Immunization Practices (1996) The role of BCG vaccine in the prevention and control of tuberculosis in the United States. A joint statement by the Advisory Council for the Elimination of Tuberculosis and the Advisory Committee on Immunization Practices. MMWR Recomm Rep 45:1-18
3. Anderson GF, Frogner BK (2008) Health spending in OECD countries: obtaining value per dollar. Health Aff (Millwood) 27:1718-1727. doi: 10.1377/hlthaff.27.6.1718
4. Bader HM, Egler P (2004) Immunisation coverage in the adult workforce 2003. Utilisation of routine occupational health checks to ascertain vaccination coverage in employees. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 47:1204-1215. doi: 10.1007/s00103-004-0942-0
5. Bayas JM, Izquierdo C, Ruiz L, Sintes X, Sousa D, Celorrio JM, Varona W, Carratala J, Nebot M, Batalla J, Sugranes S, Manzur A, Terren A, Garcia C, Clemente E, Rivera S, Justo I, Arevalo A, Salleras L, Dominguez A (2009) Validity of self-reported pneumococcal vaccination status in the elderly in Spain. Vaccine 27:4560-4564. doi: 10.1016/j.vaccine.2009.05.057
6. Beytout J, Denis F, Giet R, Allaert FA (2004) Regional variations of adult population vaccinal status. Med Mal Infect 34:460-468
7. Blank PR, Schwenkglenks M, Szucs TD (2009) Vaccination coverage rates in eleven European countries during two consecutive influenza seasons. J Infect 58:446-458. doi: S0163-4453(09)00115-7
8. Centers for Disease Control and Prevention (2010) Final estimates for 2009-2010 seasonal influenza and influenza A (H1N1) 2009 monovalent vaccination coverage - United States, August 2009 through May, 2010. Atlanta, GA: US Department of Health and Huma Services, CDC; 2010. Available at: http://www.cdc.gov/flu/professionals/vaccination/coverage-0910estimates.htm
9. de Miguel AG (2006) Strategies of vaccination for adult population in Spain in the actuality. An R Acad Nac Med (Madr) 123:175-194
10. del Corro MR, Vargas-Roman MI, Garcia RI, Prieto RG, de Miguel AG (2009) Tetanus vaccination in adult population: coverage, registration and compliance. Hum Vaccin 5:98-104. doi: 6588
11. Dorleans F, Giambi C, Dematte L, Cotter S, Stefanoff P, Mereckiene J, O'Flanagan D, Lopalco PL, D'Ancona F, Levy-Bruhl D (2010) The current state of introduction of human papillomavirus vaccination into national immunisation schedules in Europe: first results of the VENICE2 2010 survey. Euro Surveill 15(47):1-4. pii: 19730
12. Gavazzi G, Wazieres B, Lejeune B, Rothan-Tondeur M (2007) Influenza and pneumococcal vaccine coverages in geriatric health care settings in france. Gerontology 53:382-387. doi: 000105166
13. Hinman AR, Orenstein WA (2007) Adult immunization: what can we learn from the childhood immunization program? Clin Infect Dis 44:1532-1535. doi: CID51162
14. International Monetary Fund (October 2009) World economic outlook database - WEO Groups and Aggregates Information. http://www.imf.org/external/ pubs/ft/weo/2009/02/weodata/groups.htm
15. Kanitz EE, Wu LA, Giambi C, Strikas RA, Levy-Bruhl D, Stefanoff P, Mereckiene J, Appelgren E, D'Ancona F (2012) Variation in adult vaccination policies across Europe: an overview from VENICE network on vaccine recommendations, funding and coverage. Vaccine 30:5222-5228. doi: S0264-410X(12)00851-1
16. Kwong JC, Rosella LC, Johansen H (2007) Trends in influenza vaccination in Canada, 1996/1997 to 2005. Health Rep 18:9-19
17. Lang PO, Govind S, Michel JP, Aspinall R, Mitchell WA (2011) Immunosenescence: implications for vaccination programmes in adults. Maturitas 68:322-330. doi: S0378-5122(11)00027-2
18. Leggat PA, Zwar NA, Hudson BJ (2009) Hepatitis B risks and immunisation coverage amongst Australians travelling to southeast Asia and east Asia. Travel Med Infect Dis 7:344-349. doi: S1477-8939(09)00058-1
19. Levine OS, Bloom DE, Cherian T, de Quadros C, Sow S, Wecker J, Duclos P, Greenwood B (2011) The future of immunisation policy, implementation, and financing. Lancet 378:439-448. doi: S0140-6736(11)60406-6
20. Mereckiene J, Cotter S, Nicoll A, Levy-Bruhl D, Ferro A, Tridente G, Zanoni G, Berra P, Salmaso S, O'Flanagan D, O Flanagan D (2008) National seasonal influenza vaccination survey in Europe, 2008. Euro Surveill 13(43):1-7. pii: 19017
21. Mereckiene J, Cotter S, Lopalco P, D'Ancona F, Levy-Bruhl D, Giambi C, Johansen K, Dematte L, Salmaso S, Stefanoff P, O'Flanagan D (2010) Hepatitis B immunisation programmes in European Union, Norway and Iceland: where we were in 2009? Vaccine 28:4470-4477. doi: S0264-410X(10)00543-8
22. Michel JP, Lang PO (2011) Promoting life course vaccination. Rejuvenation Res 14:75-81. doi: 10.1089/rej.2010.1078
23. Michel JP, Chidiac C, Grubeck-Loebenstein B, Johnson RW, Lambert PH, Maggi S, Moulias R, Nicholson K, Werner H (2009) Advocating vaccination of adults aged 60 years and older in Western Europe: statement by the Joint Vaccine Working Group of the European Union Geriatric Medicine Society and the International Association of Gerontology and Geriatrics-European Region. Rejuvenation Res 12:127-135. doi: 10.1089/rej.2008.0813
24. Montrieux C, Collette G, Limme C, Seidel L, Albert A, Giet D (2002) Evaluation of tetanus vaccine coverage in rural society. Rev Med Liege 57:97-103
25. Nielsen US, Petersen E, Larsen CS (2009) Hepatitis B immunization coverage and risk behaviour among Danish travellers: are immunization strategies based on single journey itineraries rational? J Infect 59:353-359. doi: 10.1016/j.jinf.2009.08.018
26. Noakes K, Pebody RG, Gungabissoon U, Stowe J, Miller E (2006) Pneumococcal polysaccharide vaccine uptake in England, 1989-2003, prior to the introduction of a vaccination programme for older adults. J Public Health (Oxf) 28:242-247. doi: fdl017
27. Osterholm MT, Kelley NS, Sommer A, Belongia EA (2012) Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis 12:36-44. doi: S1473-3099(11)70295-X
28. Pebody RG, Hippisley-Cox J, Harcourt S, Pringle M, Painter M, Smith G (2008) Uptake of pneumococcal polysaccharide vaccine in at-risk populations in England and Wales 1999-2005. Epidemiol Infect 136:360-369. doi: S0950268807008436
29. Personal communication with Hajime Kamiya, Research/Medical Officer at the Japan National Institute of Infectious Diseases. 16 April 2010
30. Poland GA, Belmin J, Langley J, Michel JP, Van Damme P, Wicker S (2010) A global prescription for adult immunization: time is catching up with us. Vaccine 28:7137-7139. doi: S0264-410X(10)01355-1
31. Postema AS, Breiman RF (2000) Adult immunization programs in nontraditional settings: quality standards and guidance for program evaluation. MMWR Recomm Rep 49:1-13
32. Roush SW, Murphy TV (2007) Historical comparisons of morbidity and mortality for vaccine-preventable diseases in the United States. JAMA 298:2155-2163. doi: 298/18/2155
33. Sammarco S, Ciofi degli Atti ML, Binkin N, D'Argenio P, Bella A (2004) Vaccine coverage survey of the elderly in 11 Italian regions. Ann Ig 16:701-708
34. Schenkel K, Radun D, Bremer V, Bocter N, Hamouda O (2008) Viral hepatitis in Germany: poor vaccination coverage and little knowledge about transmission in target groups. BMC Public Health 8:132. doi: 10.1186/1471-2458-8-132
35. Schiller J, Euler G (2008) Vaccination coverage estimates from the National Health Interview Survey: United States, 2008. Centers for Disease Control and Prevention. http://www.cdc.gov/nchs/data/hestat/vaccine-coverage. htm. Accessed 8 March 2010
36. Stuck AE, Kharicha K, Dapp U, Anders J, von Renteln-Kruse W, Meier-Baumgartner HP, Harari D, Swift CG, Ivanova K, Egger M, Gillmann G, Higa J, Beck JC, Iliffe S (2007) Development, feasibility and performance of a health risk appraisal questionnaire for older persons. BMC Med Res Methodol 7:1. doi: 1471-2288-7-1
37. The Community Guide (October 2008) Universally recommended vaccinations: reducing client out-of-pocket costs for vaccinations (abbreviated). www.thecommunityguide.org/vaccines/universally/clientoutofpocketcosts.html
38. The World Bank (2010a) GDP per capital (current US) table. http://data.worldbank.org/indicator/NY.GDP.PCAP.CD
39. The World Bank (2010b) Health expenditure per capita (current US) table. http://data.worldbank.org/indicator/SH.XPD.PCAP
40. The World Bank (2010c) Out-of-pocket health expenditure (% of private expenditure of health) table. http://data.worldbank.org/indicator/SH.XPD.OOPC.ZS
41. The World Bank (2010d) Population total table. http://data.worldbank.org/ indicator/SP.POP.TOTL
42. van Houdt R, Koedijk FD, Bruisten SM, Coul EL, Heijnen ML, Waldhober Q, Veldhuijzen IK, Richardus JH, Schutten M, van Doornum GJ, de Man RA, Hahne SJ, Coutinho RA, Boot HJ (2009) Hepatitis B vaccination targeted at behavioural risk groups in the Netherlands: does it work? Vaccine 27:3530-3535. doi: 10.1016/j.vaccine.2009.03.072
43. Viechtbauer W (2010) Conducting meta-analyses in R with the metafor package. J Stat Softw 36:1-48
44. Weir R, Jennings L, Young S, Brunton C, Murdoch D (2009) National serosurvey of vaccine preventable diseases. Ministry of Health, Wellington
45. World Health Organization (WHO) and United Nations Children's Fund (UNICEF) (2005) Global Immunization vision and strategy, 2006-2015. World Health Organization and United Nations Children's Fund, Geneva
46. Zepp F, Heininger U, Mertsola J, Bernatowska E, Guiso N, Roord J, Tozzi AE, Van Damme P (2011) Rationale for pertussis booster vaccination throughout life in Europe. Lancet Infect Dis 11:557-570. doi: S1473-3099(11)70007-X